Piper Sandler & Co’s Precigen PGEN Stock Holding History

Piper Sandler & Co’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-5,232	Closed	-$119K	–	115
2013 Q4	$119K	Buy	+5,232	New	+$106K	0.1%	83

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Piper Sandler & Co's PGEN Position: Q1 2014 in Review

Piper Sandler & Co sold out of Precigen (PGEN) in Q1 2014, closing a stake of 5,232 shares — an estimated $119K sold.

Piper Sandler & Co first reported a position in PGEN in Q4 2013 and held it in 1 quarter. The position peaked at $119K in Q4 2013. 100 funds tracked by Wall St. Rank hold PGEN as of Q1 2014.

Piper Sandler & Co reported no remaining Precigen position as of Q1 2014 after selling out during the quarter.
Piper Sandler & Co sold 5,232 Precigen shares in Q1 2014, an estimated $119K.
Piper Sandler & Co first reported a position in Precigen in Q4 2013 and held it in 1 quarter.
Piper Sandler & Co's Precigen position peaked at $119K in Q4 2013.
100 funds tracked by Wall St. Rank held Precigen as of Q1 2014.

Based on Piper Sandler & Co's 13F filing for Q1 2014, filed 15 May 2014.